de Ruiter, Ben-Max
60  results:
Search for persons X
?
7

Bladder-sparing chemoradiotherapy combined with immune chec..:

van Hattum, Jons W ; de Ruiter, Ben-Max ; Oddens, Jorg R...
https://research.vumc.nl/en/publications/73c0545f-d20a-41cd-bc2a-1516ba12b9f1.  , 2022
 
?
8

Bladder-sparing chemoradiotherapy combined with immune chec..:

van Hattum, Jons W ; de Ruiter, Ben-Max ; Oddens, Jorg R...
https://research.vumc.nl/en/publications/73c0545f-d20a-41cd-bc2a-1516ba12b9f1.  , 2022
 
?
9

A Multicenter Retrospective Cohort Series of Muscle-invasiv..:

de Ruiter, Ben-Max ; van de Kamp, Maaike W ; van Steenbergen, Jonah P. Z...
https://research.vumc.nl/en/publications/c9a03d02-dc35-438b-8f1d-c516db5b7aa9.  , 2022
 
?
10

A Multicenter Retrospective Cohort Series of Muscle-invasiv..:

de Ruiter, Ben-Max ; van de Kamp, Maaike W ; van Steenbergen, Jonah P. Z...
https://research.vumc.nl/en/publications/c9a03d02-dc35-438b-8f1d-c516db5b7aa9.  , 2022
 
?
11

Quality of Life following Chemoradiotherapy for Localized M..:

de Ruiter, Ben-Max ; Keijzer, Abel N ; Hulshof, Maarten C. C. M...
https://research.vumc.nl/en/publications/b551c4ff-e57a-4cb5-a0cf-91c147fae120.  , 2021
 
?
12

Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ..:

de Ruiter, Ben Max ; van Hattum, Jons W ; Lipman, Djoeri...
https://research.vumc.nl/en/publications/340c7361-8e41-4747-9c1a-4472a02d1930.  , 2022
 
?
13

Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ..:

de Ruiter, Ben Max ; van Hattum, Jons W ; Lipman, Djoeri...
https://research.vumc.nl/en/publications/340c7361-8e41-4747-9c1a-4472a02d1930.  , 2022
 
?
14

The Effect of Metformin on Bladder Cancer Incidence and Out..:

van Hattum, Jons W ; de Ruiter, Ben Max ; Oddens, Jorg R...
https://research.vumc.nl/en/publications/7bf6006e-9328-415f-92a3-0c100f4c20d2.  , 2022
 
?
15

A Multicenter Retrospective Cohort Series of Muscle-invasiv..:

de Ruiter, Ben Max ; van de Kamp, Maaike W ; van Steenbergen, Jonah P.Z...
https://pure.eur.nl/en/publications/3c5ae6c5-5161-45eb-beb9-77682e611d8f.  , 2022
 
1-15